Clinical Trial Update: Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial updating the use of Interleukin-2 therapy for autoimmunity in Type 1 diabetes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: University of Oxford | Conditions: Type1 Diabetes | Phase 2 | Status: ACTIVE_NOT_RECRUITING